Price $31.35 |
Market Cap
1.23B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.53
|
P/S
5.57
|
Dividend %
-
|
|
P/CF
488.2
|
P/FCF
-
|
Op. Cash Flow
-8.8K
|
FCF
-0.4
|
|
Op. Margin
-13.20%
|
Net Margin
-14.40%
|
ROE
-17.00%
|
ROI
-12.00%
|
|
ROA
-10.00%
|
EPS Growth
19.10%
|
Current Ratio
2.6
|
Debt/Equity
22.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| TearLab Corp (TEAR) | $0.09 | - | - | 1M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.20 | - | - | 63.8M | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $10.55 | - | - | 1.42B | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
| Stereotaxis Inc (STXS) | $1.51 | - | - | 66.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
